TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
ESPR

Esperion Therapeutics Inc

Healthcare · Drug Manufacturers - Specialty & Generic

3.20$ +0.0% vs. previous close Closing price · As of: Jul 15, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow ESPR
Line item 1999 2000 2001 2002 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – – – – – – – – – – –
– – – – – -21.9% -49.4% +126.8% +47.5% +6.8% +2.4% +2.7% +20.4% +71.5% +11.9% -18.3% -67.2% -61.6% +66.7%
– – – – – +1.8% +1,436.4% +199.8% +245.9% +25.4% +16.6% +28.8% +8.0% +9.7% -14.4% -37.4% -21.4% +0.3% -17.7%
– – – – – – – -10.6% +244.3% +24.9% +16.6% +28.8% +8.0% +9.7% -23.7% -29.8% – – –
– +60.0% -135.8% – – -204.8% – -92.2% -932.3% – +65.0% +77.1% -125.0% – – – – -542.6% –
– -14.2% +50.9% -42.9% -97.1% -79.8% +362.5% +2,682.6% -62.8% -71.1% -79.8% +694.7% +531.1% +1,302.8% -100.0% – – – -40.4%
– +29.5% +5.1% +157.5% – -100.3% +1,247,798.9% +74.3% +337.4% – -454.3% – -54.3% -66.8% -336.4% – +424.4% -100.7% –
– – – – – – – – – – – – – – -100.0% – – – –
– – – – – – – +27.5% +107.3% -100.0% +366,937.8% -92.9% +0.2% -567.3% – -59.2% – – –
– – – – – – – – -113.2% +151.4% +6.5% -38.6% – -19.4% -100.2% -100.0% – – -256.8%
– +2,926.6% -70.3% -94.2% +366.1% +134.5% +466.0% +9.0% +96.2% -100.8% – -93.5% +1,173.6% +48.1% +33.0% -87.8% +54.8% +71.4% -58.2%
– – -99.9% -51,456.9% – – +912.6% -43.0% -127.0% – – – +5,093.0% +6.0% -133.4% – – – -63.1%
– – – – – – – – – – – – – – – – – – –

Data as of: July 15, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?